ArticlePloS one2026
Use as directed? A comparison of software tools intended to check rigor and transparency of published work.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Open Science Policies and Practices Among Medical Journals.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The causes of the reproducibility crisis include lack of standardization and transparency in scientific reporting. Checklists such as ARRIVE and CONSORT seek to improve transparency, but they are not always followed by authors and peer review often fails to identify missing items. To address these issues, there are several automated tools that have been designed to check different rigor criteria. We have conducted a broad comparison of 11 automated tools across 9 different rigor criteria from the ScreenIT group. We found some criteria, including detecting open data, where the combination of tools showed a clear winner, a tool which performed much better than other tools. In other cases, including detection of inclusion and exclusion criteria, the combination of tools exceeded the performance of any one tool. We also identified key areas where tool developers should focus their effort to make their tool maximally useful. We conclude with a set of insights and recommendations for stakeholders in the development of rigor and transparency detection tools. The code and data for the study is available at https://github.com/PeterEckmann1/tool-comparison.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.